Merkel cell carcinoma – current therapeutic options

Bibliography

• MILLER RW, RABKIN CS: Merkel cell carcinoma and melanoma: etiological similarities and. Cancer Epidemiol Biomarkers Prey. (1999) 8(2):153–158.
   PubMedGoogle Scholar
• ••Provides a pro-surgical approach to earlystage MCC.
   Google Scholar
• POULSEN M, RISCHIN D, WALPOLE E et al.: Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatinietoposide and radiation: a Trans-Tasman Radiation Oncolgy Group Study. Lat.': Rad. Oncol Biol. Phys. (Huntingt) (2001) 51(1):156–163.
   PubMedGoogle Scholar
• SUNTHARALINGAM M,RUDOLTZ MS, MENDENHALL WM, PARSONS JT, STRINGER SP,MILLION RR: Radiotherapy for merkel cell carcinoma of the skin of the head and neck. Head Neck (1995) 17:96–101.
   PubMedGoogle Scholar
• ALLEN PJ, ZHANG ZF, COIT DG: Surgical management of Merkel cell carcinoma. Ann. Surg. (1999) 229(1):97–105.
   PubMed Web of Science ®Google Scholar
• ••Provides a pro-surgical approach to earlystage MCC.
   Google Scholar
• HAAG M, GLASS LF, FENSKE NA: Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg. (1995) 21:669–683.
   PubMed Web of Science ®Google Scholar
• ••A comprehensive review of treatment-related issues.
   Google Scholar
• RATNER D, NELSON BR,BROWN MD, JOHNSON TM: Merkel cell carcinoma. .1 Am. Acad. Berm. (1993) 29:143–156.
   Google Scholar
• AL GHAZAL SK, ARORA DS, SIMPSON RH, SAXBY P: Merkel cell carcinoma of the skin. Br. J. Plast. Stag. (1996) 49(7):491–496.
   PubMedGoogle Scholar
• YIENGPRUKSA WAN A, COIT D, THALER H, URMACHER C,KNAPPER W: Merkel cell carcinoma:prognosis and Management. Arch. Surg. (1991) 126:151441519).
   Google Scholar
• ROENIGK R, GOLTZ R: Merkel cell carcinoma: a problem with micrographically controlled surgery. I Dermatol Surg. Oncol (1986) 12:332–336.
   PubMedGoogle Scholar
• RUBSAMEN P, TANENBAUM M, GROVE AS, GOULD E.: Merkel cell carcinoma of the eyelid and periorbital tissues. Am. .1. Ophthalmol (1992) 113:674–680.
   Google Scholar
• MEEUWISSEN J, BOURNE R,KEARSLEY J: The importance of post operative radiotherapy in the treatment of merkel cell carcinoma. Int. J. Radiation °flea Biol. Phys. (1995) 31:325–331.
   PubMed Web of Science ®Google Scholar
• •Provides a sound case for the importance of postoperative radiotherapy.
   Google Scholar
• MORRISON W, PETERS L, SILVA E, VVENDT C, ANG K, GOEPFERT H: The essential role of radiation therapy is securing locoregional control of Merkel Cell Carcinoma. hat. I Radiation °flea Biol. Phys. (1990) 19:583–591.
   PubMed Web of Science ®Google Scholar
• FENIG E, BRENNER B, KATZ A, RAKOVSKY E, HANA MB, SULKES A: The role of radiation therapy and chemotherapy in the treatment of merkel cell carcinoma. Cancer (1997) 80:881–885.
   PubMed Web of Science ®Google Scholar
• ASHBY M, JONES DH, TASKER AD, BLACKSHAW AJ: Primary cutaneous neuroendocrine (Merkel cell or trabecular carcinoma) tumour of the skin: a radiosensitive tumour. Clin. Radio]. (1989) 40:85–87.
   PubMedGoogle Scholar
• PILOTTI S, RILKE F, BARTOLI C, GRISOTTI A: Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma. J. Clin. Oncol (1988) 6:1863–1873.
   PubMed Web of Science ®Google Scholar
• OTT MJ, TANABE KK, GADD MA et al.:Multimodality management of Merkel cell carcinoma. Arch. Surg. (1999) 134(4):388–392.
   PubMed Web of Science ®Google Scholar
• BOYLE F, PENDLEBURY S, BELL D: Further insights in to the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int. J. Radiation Oncol Biol. Phys. (1995) 31:315–323.
   PubMed Web of Science ®Google Scholar
• PACELLA J, ASHBY M, AINSLIE J, MINTY C: The role of radiotherapy in the management of primary cutaneous neuroendocrine tumours: experience of the Peter MacCallum Cancer Institute (Melbourne Australia).14. hat. J. Radiation. °flea Biol. Phys. (1988) 14:1077–1084.
   PubMed Web of Science ®Google Scholar
• VICTORS, MORTON B, SMITH J: Merkel cell carcinoma: is prophylactic lymph node dissection indicated? Am. Surg. (1996) 62:879–882.
   Google Scholar
• BOURNE R: Management of Merkel cell tumour. Aust. NZ Surg. (1988) 58:971–974.
   PubMedGoogle Scholar
• HILL AD, BRADY MS, COIT DG: Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br. J. Surg. (1999) 86(4):518–521.
   PubMedGoogle Scholar
• SHAW JH, RUMBALL E: Merkel cell tumour: clinical behaviour and treatment. Br. J. Surg. (1991) 78:138–142.
   PubMed Web of Science ®Google Scholar
• LEONARD JH, RAMSAY JR,KEARSLEY JH, BIRRELL GW: Radiation sensitivity of Merkel cell carcinoma cell lines. bit.J Radiat. °flea Biol. Phys. (1995) 32:1401–1407.
   PubMedGoogle Scholar
• TENNVALL J, BIORKLUND A, JOHANSSON L, AKERMAN M: Merkel cell carcinoma: management of primary, recurrent and metastatic disease: a clinicopathological study of 17 patients. Eur. Surg. Oncol (1989) 15:1-9. 2191Expert Op/n. Pharmacother. (2003) 4(1 2)
   Google Scholar
• RAAF JH, URMACHER C, KNAPPERWK, SHIU MH, CHENG EW: Trabecular (Merkel cell) carcinoma of the skin. Treatment of primary, recurrent and metastatic disease. Cancer (1986) 57:178–182.
   Google Scholar
• MARKS M, KIM R, SALTER M: Radiotherapy as an adjunct in management of Merkel cell carcinoma. Cancer (1990) 65:60–64.
   PubMed Web of Science ®Google Scholar
• GOEPFERT H, REMMLER D, SILVA E, WHEELER B: Merkel cell carcinoma (endocrine carcinoma of skin) of the head and neck. Arch. Otularyngul (1984) 110:707–712.
   PubMedGoogle Scholar
• KOKOSKA ER, KOKOSKA MS, COLLINS BT, STAPLETON DR, WADE TP: Early aggressive treatment for Merkel cell carcinoma improves outcome. Am. J. Surg. (1997) 174(6):688–693.
   PubMedGoogle Scholar
• KEARSLEY J, HURST T, KHOO S: Chemosensitivity testing of primary cultures of merkel cell cancer.Anticancer Drugs (1993) 4:571–575.
   PubMedGoogle Scholar
• FENIG E, BRENNER B, NJUGUNA E, KATZ A, SCHACHTER J, SULKES A: Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide. Am. J. Clin. Once]. (2000) 23(1):65–67.
   PubMedGoogle Scholar
• FEUN L, SAVARAJ N, LEGHA S, SILVA E, BENJAMIN R, BURGESS M: Chemotherapy for metastatic Merkel cell carcinoma. Review of the MD Anderson Hospital's experience. Cancer (1988) 62:683–685.
   Google Scholar
• SHARMA D, FLORA G,GRUNSBERG S: Chemotherapy of metastatic merkel cell carcinoma: case report and review of the literature. Am. J. Clin. Once]. (1991) 14:166–169.
   PubMed Web of Science ®Google Scholar
• VOOG E, BIRON P, MARTIN JP,BLAY JY: Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer (1999) 85(12):2589–2595.
   PubMed Web of Science ®Google Scholar
• TAI PT, YU E, WINQUIST E et al: Chemotherapy in neuroendocrine/merkel cell carcinoma of the skin and review of 204 cases. J. Clin. Once]. (2000) 18:2493–2499.
   PubMed Web of Science ®Google Scholar
• ••A good review of chemotherapy for MCC.
   Google Scholar
• GOESSLING W, MCKEE PH, MAYER R: Merkel cell carcinoma. .1 Clin. Once]. (2002) 20(2):588–598.
   Google Scholar
• ••An excellent up-to-date review of MCC.
   Google Scholar
• CAL VERT AH, NEWELL DR,GUMBRELL LA et al.: Carboplatin dosage: prospective evaluation of a simple formula based on renal function. Clin. Once]. (1989) 7:1748–1756.
   Google Scholar
• SLICHENMYER WJ, LEMAISTRE CE VON HOFF DD: Response of metastatic adenoid cystic carcinoma and Merkel cell tumour to high-dose melphalan with autologous bone marrow transplantation. New Drugs (1992) 10:45–48.
   Google Scholar
• WALDMANN V, GOLDSCHMIDT H, JACKEL A et al.: Transient complete remission of metastasized Merkel cell carcinoma by high dose polychemotherapy and autologous peripheral blood stem transplantation. Br. J. Dermatul (2000) 143:837–839.
   PubMedGoogle Scholar
• DAVIS M, MILLER EM, RAU RC, JOHNSON OE, NAILLE RA, CRNKOVICH MJ: The use of VP16 and cisplatin in the treatment of Merkel cell carcinoma. J. Dermatol Surg. Once]. (1990) 16:276–278.
   PubMedGoogle Scholar
• ••Provides an excellent up-to-date review onMCC.
   Google Scholar
• POULSEN M: I Clin. Once]. (2003) 21 (In Press).
   Google Scholar
• HATA Y, MATSUKA K, ITO 0 et al.: Twocases of Merkel cell carcinoma cured by intratumour injection of natural human tumour necrosis factor. Plast. Reconstr. Surg. (1997) 99:547–553.
   Google Scholar
• OLIEMAN AF, LIENARD D,EGGERMONT AM et al.: Hyperthermic isolated limb perfusion with tumournecrosis factor, interferon gamma, and melphalan for locally advanced non melanomatous skin tumours of the extrematies:a multicentre study. Arch. Surg. (1999) 134(3):303–307.
   Google Scholar
• BAJETTA E, ZILEMBO N,DI BARTOLOMEO M et al.: Treatment of metastatic carcinoids and other neuroendocrine tumours with recombinant interferon-alpha-2a: a study by the Italian Trials in Medical Oncology Group. Cancer (1993) 72:3099–3105.
   Google Scholar
• ZILEMBO N, BUZZONI R, BAJETTA E et al.: Salvage treatment after r-interferon alpha-2a in advance neuroendocrine carcinoma. Acta Once]. (1993) 32:245–250.
   PubMed Web of Science ®Google Scholar
• DURAND JM, WEILLER C,RICHARD MA, PORTAL I,MONGIN M: Treatment of Merkel cell tumour with interferon-alpha-2b. Br. J. Dermatul (1991) 124:509.
   PubMed Web of Science ®Google Scholar
• DI BARTOLOMEO M, BAJETTA E, BUZZONI R et al.: Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumours. A study by the Italian Trials in Medical Oncology Group. Cancer (1996) 77:402–408.
   Google Scholar
• DAWSON R, WILLIAMS OM, MANSEL RE: Isolated hyperthermic limb perfusion chemotherapy in Merkel cell tumour. I R. Cull. Surg. Edinb. (1996) 41(4):255–256.
   PubMedGoogle Scholar